Fundraising FoxNeuwave Medical
Madison, US · Founded 2015 · Wisconsin corporation · 1 known investors
Find your way into Neuwave Medical
Sign up to see every warm intro you have to Neuwave Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuwave Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuWave Medical develops the NeuWave Microwave Ablation System, a device used by healthcare professionals to ablate soft tissue, including non-resectable liver tumors, in percutaneous, open surgical, and laparoscopic settings. The system includes a probe portfolio and ABLATE-IQ software for margin confirmation, and is marketed for use in the United States; the company is a wholly owned subsidiary of Quantum Surgical, Inc.
Founders & leadership
Neuwave Medical was founded in 2015 by Fred T. Lee, Jr..
FT
Fred T. Lee, Jr.Founder
AM
Aaron MarshallExecutiveAaron Marshall brings experience from spine surgery and medical device sales, with background in clinical sales, capital equipment sales, medical education, and R&D.
DS
Daniel SullivanExecutive
DJ
Daniel Joseph Sullivan IIIExecutive
Board
JM
John MurphyBoard director
SC
Scott CramerBoard director
SB
Scott ButtonBoard director
MW
Michael WassermanBoard director
KN
Kirk NielsenBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$30.1M disclosed across 2 rounds · 2014–2015
▶$25.3MraisedMay 2015 · 38 investors · BiotechnologyRule 506(b)
▶$25.3MraisedMay 2015 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John MurphyDirector
- Scott CramerDirector
- Scott ButtonDirector
- Fred T. Lee, Jr.Executive Officer, Director
- Aaron MarshallExecutive Officer
- Daniel SullivanExecutive Officer, Director
- Michael WassermanDirector
- Kirk NielsenDirector
- Offering amount
- $25.3M
- Amount sold
- $25.3M
- First sale
- May 2015
- Incorporated
- Corporation, Wisconsin, 2015
- Federal exemptions
- 06b
▶$4.8MraisedOct 2014 · 31 investors · Other Health CareRule 506(b)
▶$4.8MraisedOct 2014 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott ButtonDirector
- John MurphyDirector
- Scott CramerDirector
- Michael WassermanDirector
- Fred T. Lee, Jr.Director
- Daniel Joseph Sullivan IIIExecutive Officer, Director
- Offering amount
- $11.6M
- Amount sold
- $4.8M
- First sale
- Sep 2014
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Quantum SurgicalQuantum Surgical develops Epione, a robotic-assisted percutaneous ablation platform that helps interventional radiologists treat inoperable or difficult early-stage tumors without surgery by guiding needle placement for tumor destruction. The company serves cancer centers and hospitals in Europe and the United States, operating in the medical robotics and interventional oncology field.
Johnson & JohnsonJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Shockwave MedicalShockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists. Its products are medical devices consisting of catheters paired with generators.
Companies working in the same space as Neuwave Medical.
Frequently asked questions
- What does Neuwave Medical do?
- NeuWave Medical develops the NeuWave Microwave Ablation System, a device used by healthcare professionals to ablate soft tissue, including non-resectable liver tumors, in percutaneous, open surgical, and laparoscopic settings. The system includes a probe portfolio and ABLATE-IQ software for margin confirmation, and is marketed for use in the United States; the company is a wholly owned subsidiary of Quantum Surgical, Inc.
- Who founded Neuwave Medical?
- Neuwave Medical was founded by Fred T. Lee, Jr. in 2015.
- Who are Neuwave Medical's investors?
- Neuwave Medical's investors include Venture Management.
- How much funding has Neuwave Medical raised?
- Neuwave Medical has disclosed $30.1M raised across 2 rounds.
- Where is Neuwave Medical headquartered?
- Neuwave Medical is headquartered in Madison, US.